Literature DB >> 530321

Increased levels of prostaglandin-like material in the canine blood during arterial hypotension produced by hydralazine, dihydralazine and minoxidil.

G Haeusler, M Gerold.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 530321     DOI： 10.1007/BF00500280

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN： 0028-1298            Impact factor:   3.000


× No keyword cloud information.
  32 in total

1.  Relation between ulcerogenic activity of various NSAID and their potency as inhibitors of prostaglandin synthesis in vivo.

Authors:  K M Strub; R K Müller
Journal:  Agents Actions Suppl       Date:  1979

2.  Metabolism of prostacyclin. Oxidation by rhesus monkey lung 15-hydroxyl prostaglandin dehydrogenase.

Authors:  J C McGuire; F F Sun
Journal:  Arch Biochem Biophys       Date:  1978-07       Impact factor: 4.013

3.  Pharmacological properties of hydrallazine, dihydrallazine and some related compounds.

Authors:  S M KIRPEKAR; J J LEWIS
Journal:  J Pharm Pharmacol       Date:  1957-12       Impact factor: 3.765

4.  [Characterization of the pharmacodynamic action spectrum of hypotensive materials].

Authors:  J TRIPOD; R MEIER
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1958

5.  Prostacyclin is produced in whole blood [proceedings].

Authors:  G J Blackwell; R J Flower; N Russell-Smith; J A Salmon; P B Thorogood; J R Vane
Journal:  Br J Pharmacol       Date:  1978-11       Impact factor: 8.739

6.  Observation on the mechanism of renin release by hydralazine in hypertensive patients.

Authors:  H Ueda; Y Kaneko; T Takeda; T Ikeda; S Yagi
Journal:  Circ Res       Date:  1970-10       Impact factor: 17.367

7.  Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac ateries and inhibits platelet aggregation.

Authors:  S Bunting; R Gryglewski; S Moncada; J R Vane
Journal:  Prostaglandins       Date:  1976-12

8.  Actions of bretylium and guanethidine on the uptake and release of [3H]-noradrenaline.

Authors:  G HERTTING; J AXELROD; R W PATRICK
Journal:  Br J Pharmacol Chemother       Date:  1962-02

9.  Studies on the mechanism of flush induced by nicotinic acid.

Authors:  R G Andersson; G Aberg; R Brattsand; E Ericsson; L Lundholm
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1977-07

10.  A sensitive method for the assay of 5-hydroxytryptamine.

Authors:  J R VANE
Journal:  Br J Pharmacol Chemother       Date:  1957-09
View more
  6 in total

Review 1.  Nifedipine interactions in hypertensive patients.

Authors:  A Salvetti; A Magagna; B Abdel-Haq; M Lenzi; R Giovannetti
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

Review 2.  Pinacidil. Preclinical investigations.

Authors:  I Ahnfelt-Rønne
Journal:  Drugs       Date:  1988       Impact factor: 9.546

3.  Interaction between oxprenolol and indomethacin on blood pressure in essential hypertensive patients.

Authors:  A Salvetti; F Arzilli; R Pedrinelli; P Beggi; M Motolese
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

4.  Influence of prostaglandin synthesis inhibitors on pulmonary vasodilatory effects of hydralazine in dogs with hypoxic pulmonary vasoconstriction.

Authors:  L J Rubin; J D Lazar
Journal:  J Clin Invest       Date:  1981-01       Impact factor: 14.808

5.  Indomethacin does not attenuate the effects of hydralazine in normal subjects.

Authors:  S H Jackson; H Pickles
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 6.  Clinical pharmacokinetics and therapeutic use of hydralazine in congestive heart failure.

Authors:  J P Mulrow; M H Crawford
Journal:  Clin Pharmacokinet       Date:  1989-02       Impact factor: 6.447
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.